In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
Page 1 of 1
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
Becker JR, Robinson TY, Sachidanandan C, Kelly AE, Coy S, Peterson RT, MacRae CA. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. Cardiovasc Res. 2012 Mar 1;93(3):463-70. doi: 10.1093/cvr/cvr350. Epub 2011 Dec 23.
Similar topics
» Human c-MYBPC3 RNA Targeted Therapy, Reversal of Hypertrophic Cardiomyopathy in the Zebrafish Model
» Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
» Natriuretic peptide precursor C coding gene contributes to zebrafish angiogenesis
» Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development
» Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy
» Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish
» Natriuretic peptide precursor C coding gene contributes to zebrafish angiogenesis
» Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development
» Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|